SOUTHWEST ONCOLOGY GROUP CA-13612

西南肿瘤学组 CA-13612

• 批准号: 6856680
• 负责人: THOMAS Patrick MILLER
• 金额: $ 11.92万
• 依托单位: UNIVERSITY OF ARIZONA
• 依托单位国家: 美国
• 财政年份: 1978
• 资助国家: 美国
• 起止时间: 1978-01-01 至 2004-03-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6856680
• 关键词: antineoplastics; bleomycin; bone marrow transplantation; brain neoplasms; breast neoplasms; cancer information system; cancer prevention; cancer registry /resource; cis platinum compound; clinical research; clinical trials; combination cancer therapy; combination chemotherapy; cooperative study; cyclophosphamide; doxorubicin; drug resistance; female reproductive system neoplasm; fludarabine; gastrointestinal neoplasms; head /neck neoplasm; hormone therapy; human subject; human therapy evaluation; ifosfamide; leukemia; lung neoplasms; lymphoma; meeting /conference /symposium; melanoma; multiple myeloma; neoplasm /cancer chemotherapy; neoplasm /cancer diagnosis; neoplasm /cancer epidemiology; neoplasm /cancer genetics; neoplasm /cancer immunotherapy; neoplasm /cancer radiation therapy; neoplasm /cancer surgery; oncology nursing; paclitaxel; pancreas neoplasms; pathology; prognosis; prostate neoplasms; quality of life; sarcoma; tamoxifen; tissue resource /registry; urinary tract neoplasms; women' s health

Description: Funding is requested to support the Arizona Cancer Center (University of Arizona) participation in Southwest Oncology Group cooperative cancer clinical research to improve the treatment of cancer in humans. Specific aims and objectives are: 1. To continue to meet current scientific leadership and core service commitments including: (A) protocol coordination (multiple studies); (B) disease/discipline committee administration; (C) reference and repository laboratory administration; and (D) group quality assurance and quality control. 2. To continue to promote the rapid integration of promising new research leads, including those developed at the Arizona Cancer Center, into cooperative group testing to improve patient treatment options and patient care. 3. To continue to meet institutional clinical research commitments in the recruitment of appropriate patients for SWOG studies and all attendant commitments to long-term follow up, quality control, etc. 4. To continue to promote community physician and patient awareness and participation in SWOG clinical trials by continued support of the Cooperative Group Outreach Program (CGOP) and other outreach and continuing education programs and activities. 5. To continue efforts to understand factors affecting accrual, particularly those in special populations (e.g., minority, elderly, financially disadvantaged), and to implement appropriate interventions where possible.

描述：要求资金支持亚利桑那癌症中心 （亚利桑那大学）参加西南肿瘤学小组 合作癌症临床研究，以改善癌症治疗 人类。 具体目标和目标是： 1。继续满足当前的科学领导力和核心服务 承诺包括：（a）协议协调（多项研究）； （b） 疾病/纪律委员会管理； （c）参考和存储库 实验室管理； （d）团体质量保证和质量 控制。 2。继续促进有前途的新研究的快速整合 铅，包括在亚利桑那癌症中心开发的铅 合作小组测试以改善患者治疗方案和患者 关心。 3。继续履行机构临床研究承诺 招募合适的患者进行吞咽研究和所有服务员 对长期跟进，质量控制等的承诺。 4。继续促进社区医师和患者的意识以及 通过继续支持 合作集团宣传计划（CGOP）和其他外展 教育计划和活动。 5。继续努力了解影响应计的因素， 特别是特殊人口的人（例如，少数，老年人， 财务不利），并实施适当的干预措施 可能的。